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Interventional treatment of renal
angiomyolipoma: immediate results
and clinical and radiological follow-up
of 4.5 years
Poul Erik Andersen, Mie Gaedt Thorlund, Gjertrud
Egge Wennevik, Rune Lau Pedersen and Lars Lund
Abstract
Background: Renal angiomyolipoma is rare, but many of these patients may have an acute debut with severe bleeding.
These patients need urgent treatment with interventional embolization as an attractive option.
Purpose: To investigate the technical and clinical effect of this treatment and to evaluate long-term clinical outcomes
with clinical control and radiological imaging.
Material and Methods: Eight patients with angiomyolipoma were treated with embolization. Five patients were
treated acutely. Five patients were followed-up for mean 4.5 years with clinical and radiological examinations.
Results: The renal angiomyolipoma decreased significantly from mean 7.2 cm to 2.9 cm after embolization (p¼ 0.04).
Cortical infarctions of about one-third of the circumference of the embolized kidneys could be detected on follow-up
examinations, but all patients had normal total kidney function. The bleeding was primarily stopped in all patients,
however, in one patient bleeding from a lumbar artery was supplementary embolized within 24 h. In another case the
interventional procedure ended up in embolization of the whole kidney as it was impossible to embolize all the feeding
arteries selectively. One patient had a nephrectomy one month after embolization because of infection and re-bleeding
and one patient after 2.5 years because of tumor size >4 cm. The technical success was 7/8 (88%) and clinical success was
6/8 patients (75%).
Conclusion: Selective embolization of renal angiomyolipoma is a minimally invasive and safe procedure with few com-
plications. It is a nephron sparing alternative to renal resection. The reduction in tumor size after embolization is
significant and long-lasting.
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Introduction
Renal angiomyolipoma (AML) is a benign renal
neoplasm composed of adipose tissue, abnormal
blood vessels, and smooth muscle cells which often
has characteristic imaging appearances on ultrasound,
computed tomography (CT) and magnetic resonance
imaging (MRI) (1–6). It is rare and constitutes only
1–2% of all tumors in the kidney and has an incidence
of about 0.3–3%; however, it is the most common
benign mesenchymal tumor in the kidney. The majority
of AMLs are isolated and occur sporadically (80%) and
are typically identiﬁed in adults with mean age at symp-
tomatic presentation of about 40 years with a strong
female predilection (F:M 4:1) (7). Up to 20% of the
AMLs occur in association with the tuberous sclerosis
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complex and occur in about 80% of these patients (8,9).
Classically, AML can be diagnosed by identifying the
negatively attenuating intra-tumor macroscopic fat
component on non-enhanced CT or on MRI (2,3).
Most AMLs are discovered incidentally in patients
who are examined for other reasons. About 40% of
the AMLs have an acute debut with severe hemorrhage
and may cause hematuria, ﬂank pain, acute abdomen,
and shock, and be potentially life-threatening as a
result of spontaneous bleeding in and outside the
tumor. The risk of bleeding is said to be proportional
to the size of the tumor, and increases signiﬁcantly with
size above 4 cm (7,10). Patients with spontaneous rup-
ture of AML and hemodynamic instability need imme-
diate treatment with interventional embolization as an
attractive option (11). The aim of this study was to
describe the immediate technical and clinical results
with long-term clinical outcomes of selective emboliza-
tion of AML.
Material and Methods
The study is a retrospective observational study from a
single center and approved by the Regional Scientiﬁc
Ethical Committees for Southern Denmark. Tracking
down patients was performed through the central
computerized patient register, through the manual
registrations of all interventional procedures at the
Department of Radiology, and the radiological infor-
mation system (RIS) and picture archiving system
Fig. 1. A 54-year-old woman (Patient 5) with spontaneous bleeding from a 4 cm angiomyolipoma laterally in right kidney.
Hemodynamically stable (a,b). Angiography 5 days later. No ongoing bleeding. Angiomyolipoma vessels (c,d). Selective distal embolization
of two segmental renal arteries with use of microcoils with following flow-stop to the angiomyolipoma (c,d). MRI at 2.5-year follow-up
demonstrating a 1.5 cm residual angiomyolipoma and a small cortical infarction with reduced cortex of the right kidney laterally (g,h,i,j).
The kidney function estimated by renography showed a left/right distribution of 63/37%. Total kidney function was normal (eGFR).
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(PACS) of the Radiologic Department at Odense
University Hospital back till 2008. In all cases of inter-
ventional embolization of renal bleedings, all available
case records and radiological imaginings were perused
and the patients ending up with the diagnosis of AML
entered the study. The diagnosis was based on clinical
ﬁndings combined with CT and angiographic ﬁndings
(Fig. 1a,b,c,d). Angiography was performed under local
anesthesia via the femoral artery. Abdominal aortogra-
phy was followed by selective right and left renal angi-
ography. The bleeding vessels were selectively
catheterized with 4F or microcatheters and embolized
with use of standard or micro coils according to the size
of the vessel being embolized (Fig. 1e,f), and in one case
with use of a supplementary vascular plug to occlude
the main renal artery.
The location and size (longest axis) of the AML on
primary CT scanning, the technical and clinical success
of the interventional treatment and follow-up of the
patients with clinical control and radiological imaging
with MRI or CT until August 2014 (Fig. 1g,h,i,j) was
investigated. The patients gave informed consent to the
follow-up study. They were clinically investigated in the
out-patient clinic, and, renal function (eGFR) was
determined, blood pressure was measured and renogra-
phy were performed at follow-up. The patients were
oﬀered MRI for follow-up and in one case where the
patient refused, a CT was performed. The study’s pri-
mary outcome measures were: overall patient survival
and nephrectomy-free survival. Secondary outcome
measures were: (i) procedural/technical success, deﬁned
as selective embolization of the bleeding vessels as
intended with following complete stop of the bleeding
with no further need of transfusions and without pro-
cedure related complications within 24 h; (ii) clinical
success, deﬁned as no recurrence of bleeding episodes
caused by the AML or complications that could be
ascribed to the embolization procedure within 30 days;
and (iii) re-interventions with embolization or surgery.
Results
In total, eight patients who underwent embolization
during the study time period were diagnosed with
AML (Table 1). There were two men and six women
with a mean age of 59 years (age range, 34–81 years).
Four AMLs were located in the right kidney and four
in the left kidney. The mean size (longest axis) of the
AMLs was 6.5 cm (range, 2–12 cm) with two <4 cm,
three 4–9 cm, and three 10 cm at admission.
Interventional treatment
Six patients had spontaneous bleedings and the AMLs
were discovered following this (Figs. 2a,b,c and 3a,b).
Five patients (patients 1, 3, 6, 7, and 8) were embolized
acutely within 12 h of symptom debut because of severe
bleeding (Fig. 3c,d,e) (Table 1). They were all hemo-
dynamically instable with low Hb, low blood pressure,
and with need of transfusions. Patient 5 was stabilized
hemodynamically on conservative treatment, and was
embolized electively after 5 days with tumor size of
4 cm because of supposed increased risk of re-bleeding.
In Patient 4 the AML was discovered incidentally, and
the interventional treatment was performed electively
after 3 months because of the big size of the AML
(12 cm). In Patient 7, the bleeding from the AML
appeared after coronary angiography, and renal
trauma by the catheter or guide wire could not be
excluded. Lastly, Patient 2 was treated without embol-
ization because of a small (3 cm) AML with self-limited
bleeding. Four months later a covered stent was
deployed in the renal artery to exclude a renal artery
aneurysm on the same side. This stent at the same time
occluded a segmental artery supplying the AML. In the
remaining seven patients coils were deployed for embol-
ization. In seven patients the embolization was selective
with embolization of estimated one-quarter to one-
third of the kidney. In one patient with technical failure
the whole kidney was embolized (Patient 4). In this
patient the intention was to treat with selective embol-
ization, but ended up with total renal embolization with
use of a supplementary vascular plug, because of
numerous supplying arteries to the tumor, which were
impossible to embolize selectively (Fig. 4a,b,c,d).
This patient had a contralateral kidney with normal
function detected at renography before the emboliza-
tion. Thus, the technical success with stop of bleeding
as intended, no re-intervention because of re-bleeding
from AML, and no associated complications within
24 h was 7/8 (88%) patients.
Patient 6, who was considered a clinical failure, had
supplementary embolization within 24 h because of new
bleeding from a lumbar artery. The other patient with
clinical failure (Patient 8) had an acute nephrectomy
1 month after the embolization because of infected
hematoma and re-bleeding from the former embolized
kidney. She had a long hospital stay with abdominal
compartment syndrome and was on dialysis for a
period, but with complete recovery. Therefore, the clin-
ical success was 6/8 (75%) patients. Patient 6 had pul-
monary emboli a couple of days after the embolization
but not related to the embolization per se and without
clinical consequences.
Follow-up
The patients were followed up until July 2014 or until
they died. The patient with nephrectomy after 1 month
was not followed up with radiological imaging.
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T
a
b
le
1
.
D
at
a
o
f
th
e
p
at
ie
n
ts
in
cl
u
d
e
d
in
th
e
st
u
d
y.
G
e
n
d
e
r/
ag
e
(y
e
ar
s)
L
o
ca
ti
o
n
/s
iz
e
lo
n
ge
st
ax
is
(c
m
)
E
m
b
o
liz
at
io
n
M
at
e
ri
al
s
E
m
b
o
liz
at
io
n
ac
u
te
/E
le
ct
iv
e
C
o
m
p
lic
at
io
n
s
co
m
m
e
n
ts
Fo
llo
w
-u
p
O
u
tc
o
m
e
1
F/
5
4
L
e
ft
ce
n
tr
al
/7
C
o
ils
A
cu
te
,
h
e
m
o
d
yn
am
ic
al
ly
in
st
ab
le
;
o
n
e
-t
h
ir
d
o
f
le
ft
k
id
n
e
y
e
m
b
o
liz
e
d
1
0
ye
ar
s,
M
R
I
2
cm
,
le
ft
/
ri
gh
t
3
9
/6
1
%
N
o
rm
al
k
id
n
ey
fu
n
ct
io
n
2
F/
5
5
R
ig
h
t/
3
C
o
ve
re
d
st
e
n
t
E
le
ct
iv
e
,
4
m
o
n
th
s;
o
n
e
-t
h
ir
d
o
f
ri
gh
t
k
id
n
e
y
e
m
b
o
liz
e
d
P
e
ri
re
n
al
h
e
m
at
o
m
a
–
n
o
p
ri
m
ar
y
in
te
rv
e
n
ti
o
n
;
an
e
u
ry
sm
ri
gh
t
re
n
al
ar
te
ry
;
h
ig
h
B
M
I
5
.5
ye
ar
s,
M
R
I
2
.5
cm
,
le
ft
/
ri
gh
t
6
2
/3
8
%
N
o
rm
al
k
id
n
ey
fu
n
ct
io
n
3
F/
3
4
L
e
ft
u
p
p
e
r
p
o
le
/1
0
C
o
ils
A
cu
te
,
h
e
m
o
d
yn
am
ic
al
ly
in
st
ab
le
;
o
n
e
-q
u
ar
te
r
o
f
le
ft
k
id
n
ey
e
m
b
o
liz
e
d
Sp
o
n
ta
n
e
o
u
s
b
le
e
d
in
g,
tr
an
sf
u
si
o
n
s
d
u
ri
n
g
tr
an
sp
o
rt
at
io
n
2
.5
ye
ar
s,
C
T
6
cm
,
le
ft
/
ri
gh
t
4
8
/5
2
%
,
n
e
p
h
re
ct
o
m
y
O
n
e
k
id
n
e
y
lo
st
–
n
o
rm
al
k
id
n
e
y
fu
n
ct
io
n
4
F/
4
4
R
ig
h
t
p
o
st
e
ri
o
r/
1
2
C
o
ils
þ
p
lu
g
E
le
ct
iv
e
,
3
m
o
n
th
s,
e
m
b
o
liz
a-
ti
o
n
o
f
w
h
o
le
ri
gh
t
k
id
n
ey
D
is
co
ve
re
d
in
ci
d
e
n
ta
lly
,
as
ym
p
to
m
at
ic
,
h
ig
h
B
M
I
2
.5
ye
ar
s
M
R
I
2
.5
cm
,
k
id
n
ey
si
ze
:
le
ft
/r
ig
h
t
1
1
.4
/5
.2
cm
,
te
ch
n
ic
al
fa
ilu
re
O
n
e
k
id
n
e
y
lo
st
–
n
o
rm
al
k
id
n
e
y
fu
n
ct
io
n
5
F/
5
4
R
ig
h
t
la
te
ra
l/
4
C
o
ils
E
le
ct
iv
e
,
5
d
ay
s,
o
n
e
-t
h
ir
d
o
f
ri
gh
t
k
id
n
ey
e
m
b
o
liz
e
d
N
o
o
n
go
in
g
b
le
e
d
in
g
d
u
ri
n
g
an
gi
o
gr
ap
hy
,t
w
o
re
n
al
ar
te
ri
e
s
2
.5
ye
ar
s,
M
R
I
1
.5
,
le
ft
/
ri
gh
t
6
3
/3
7
%
N
o
rm
al
k
id
n
ey
fu
n
ct
io
n
6
M
/8
1
L
e
ft
lo
w
e
r
p
o
le
/4
C
o
ils
A
cu
te
,
h
e
m
o
d
yn
am
ic
al
ly
in
st
ab
le
,
o
n
e
-t
h
ir
d
o
f
le
ft
k
id
n
ey
e
m
b
o
liz
e
d
C
o
n
ge
n
it
al
si
n
gl
e
k
id
n
e
y,
su
p
p
le
m
e
n
ta
ry
e
m
b
o
l-
iz
at
io
n
o
f
lu
m
b
ar
ar
te
ry
2
.5
ye
ar
s,
d
e
ad
b
e
ca
u
se
o
f
ly
m
p
h
o
m
a,
n
o
re
la
ti
o
n
to
A
M
L
,
cl
in
ic
al
fa
ilu
re
N
o
rm
al
k
id
n
ey
fu
n
ct
io
n
7
M
/7
5
L
e
ft
lo
w
e
r
p
o
le
/2
C
o
ils
A
cu
te
,
h
e
m
o
d
yn
am
ic
al
ly
in
st
ab
le
,
o
n
e
-t
h
ir
d
o
f
le
ft
k
id
n
ey
e
m
b
o
liz
e
d
A
ft
e
r
co
ro
n
ar
y
an
gi
o
g-
ra
p
hy
an
d
P
C
I
p
e
ri
re
n
al
b
le
e
d
in
g,
B
M
I
3
4
2
w
e
e
k
s,
d
e
ad
af
te
r
C
A
B
G
fo
r
ca
rd
ia
c
re
a-
so
n
s,
n
o
re
la
ti
o
n
to
A
M
L
N
o
rm
al
k
id
n
ey
fu
n
ct
io
n
8
F/
7
4
R
ig
h
t
u
p
p
e
r
p
o
le
/1
0
C
o
ils
A
cu
te
,
h
e
m
o
d
yn
am
ic
al
ly
in
st
ab
le
,
o
n
e
-t
h
ir
d
o
f
ri
gh
t
k
id
n
ey
e
m
b
o
liz
e
d
P
o
st
e
m
b
o
liz
at
io
n
:
h
e
m
o
-
d
ia
ly
si
s
an
d
in
fla
m
m
a-
ti
o
n
C
R
P
>
4
0
0
,
b
la
d
d
e
r
p
re
ss
u
re
u
p
to
2
2
m
m
H
g;
sl
o
w
,
b
u
t
co
m
p
le
te
re
co
ve
ry
C
T
n
o
b
le
e
d
in
g
af
te
r
3
d
ay
s,
ac
u
te
n
e
p
h
re
c-
to
m
y
af
te
r
1
m
o
n
th
b
e
ca
u
se
o
f
in
fe
ct
e
d
h
e
m
at
o
m
a
an
d
re
-
b
le
e
d
in
g,
cl
in
ic
al
fa
ilu
re
O
n
e
k
id
n
e
y
lo
st
–
n
o
rm
al
k
id
n
e
y
fu
n
ct
io
n
4 Acta Radiologica Open 4(7)
Fig. 2. An 81-year-old man (Patient 6) with a congenital single kidney with a severe spontaneous retroperitoneal bleeding from a 4 cm
angiomyolipoma in the lower pole of left kidney (a,b,c). He was hemodynamically unstable with low blood pressure and had several
blood transfusions. About one-quarter of the kidney was selectively embolized and he recovered completely with normal kidney
function (eGFR).
Fig. 3. A 74-year-old woman (Patient 8) hemodynamically instable with massive bleeding from a 10 cm angiomyolipoma in the right
upper pole (a,b). Angiography demonstrating several small aneurysms in relation to the angiomyolipoma (c,d). About one-third of the
kidney was selectively embolized with use of microcoils (e). She had a compartment syndrome with bladder pressure up to 22 mmHg
and inflammation after embolization and was on hemodialysis for a period, but recovered slowly and completely.
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Otherwise, no intercurrent renal bleeding episodes were
registered in any patient. Disease-speciﬁc survival of the
entire cohort was 100%. Two patients (Patients 6 and
7) died during the follow-up period (2.5 years and 2
weeks). Patient 7 died 2 weeks after suﬃcient AML
embolization. He was a 75-year-old man with unstable
angina and myocardial infarction. He died following
coronary artery bypass surgery because of heart failure
without relation to the AML. The other patient
(Patient 6) died 2.5 years after the embolization because
of lymphoma without relation to the AML. Three out
of the eight patients (38%) lost a kidney: one during the
embolization procedure (Patient 4) and two during
follow-up by nephrectomy (Patient 8 4 weeks after
embolization and Patient 3 2.5 years after the embol-
ization). In the latter case, the AML had decreased in
size from 10 cm before embolization to 6 cm after, but
the nephrectomy was performed based on a clinical
decision to prevent the supposed increased risk of
bleeding because of AML size over 4 cm. Thus ﬁve
patients were followed up for a mean of 4.5 years
(range, 2.5–10 years) with clinical examinations, blood
Fig. 4. A 44-year-old woman (Patient 4) with an incidentally discovered 12 cm angiomyolipoma posterolaterally in the right kidney
(a,b). Renography showed a distribution left/right kidney 59/41%. Selective embolization was intended, but was not possible and the
procedure ended-up with embolization of the whole kidney with coils and a supplementary vascular plug (c,d). Follow-up after 7
months with CT (upper left, Hounsfields units [HU] of residual angiomyolipoma was –100) (e). After 2.5 years (f,g,h) MRI showed
angiomyolipoma size 2.5 cm, right kidney size 5.2 cm, and left kidney size 11.4 cm. The total kidney function was normal (eGFR).
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samplings and MRI in four cases, and CT in one case
(Table 1). The size (longest axis) of the AML in these
ﬁve patients had decreased signiﬁcantly from median
7 cm to 2.5 cm (64%) and mean 7.2 cm to 2.9 cm
(60%) (P¼ 0.04, paired samples t-test). In all patients
cortical infarctions of about one-third of the circumfer-
ence of the kidneys could be detected on follow-up
examinations (Fig. 5). We have had no cases of re-
growth of the AML, and no revascularizations or insuf-
ﬁcient embolizations. All patients had normal total
kidney function (eGFR) with a renographic distribu-
tion of about one-third on the embolized kidney and
two-thirds on the non-embolized kidney (Table 1). All
patients had normal blood pressure, one patient on
treatment with three diﬀerent antihypertensive drugs,
two with one antihypertensive drugs, and the rest with-
out medical treatment. All patients declared to be in
good health.
Discussion
In the present study we have shown the eﬃcacy of
selective embolization of AML in stopping acute bleed-
ing and in reducing the volume of the AMLs.
There have been no cases with regrowth of the
tumors. The procedure has been demonstrated to
have few complications during a long follow-up
period. Although our study is small the long-term
results are comparable to others (12–14). We used
coils in all cases but one for embolization. It has also
been shown by others that embolization of AML pro-
duces durable long-term results regardless of the choice
of embolic agent (12).
Small (<4 cm) AMLs found incidentally have trad-
itionally been managed conservatively based on their
lack of malignancy and decreased propensity for hem-
orrhage, but follow-up is recommended to assess for
growth. Tumors >4 cm or those that have been symp-
tomatic can be selectively embolized or resected with
partial or radical nephrectomy. Resection, however,
will often end up with total nephrectomy (13,15).
There are no evidence-based recommendations whether
to prophylactic embolize non-symptomatic >4 cm
tumors when incidentally discovered. If the AML is
predominantly composed by fat and poorly vascular-
ized without aneurysms the bleeding risk is most prob-
ably low. The priority of treatment of AML is renal
function preservation. Several other modalities besides
selective embolization and surgical excision of the
lesion have emerged during the last years for
nephron-sparing approaches. These include laparo-
scopic and percutaneous ablative therapies such as
radiofrequency ablation, cryo-ablation, microwave
ablation, and robot-assisted laparoscopic partial neph-
rectomy (7). There is no evidence which modality is the
best and local experience and expertise will often be
decisive for which modality is preferred. There are no
published comparative randomized trials between sur-
gical excision and embolization, most probably because
AML is a rare disease (16). Selective embolization of
segmental arteries that supply the tumor is, however, by
many considered the most eﬀective minimally invasive
approach in preventing hemorrhagic events and symp-
tomatic manifestations. The procedure is well tolerated
and is associated with few complications, but we have
had three patients who lost a kidney by nephrectomy or
total kidney embolization. The procedure has been said
to be associated with more relapses compared with sur-
gical alternatives (17). We had only one supplementary
embolization (of a lumbar artery) within 24 h after pri-
mary AML embolization in contrary to 30–37% of
recurrent symptoms in other publications, most of
them in the group of tuberous sclerosis (17,18).
Lesions that present with retroperitoneal hemorrhage
often require emergency embolization as a life-saving
measure. On angiography AMLs are hypervascular
lesions, typically with micro or macro aneurysms
(Fig. 3b), and they are sharply marginated with dense
early arterial network and late whorled appearance.
The demonstration of fatty attenuation in renal
tumor on CT, MRI, and MR- or sonoelastography
Fig. 5. A 54-year-old woman (Patient 1) 10 years after acute
embolizaton of spontaneous bleeding from a 7 cm angiomyoli-
poma in left kidney. About one-third of the kidney was selectively
embolized. At follow-up the residual tumor measured 2 cm and
the renographic functional distribution of left/right kidney was
39/61% and the total kidney function (eGFR) was normal.
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studies (19) is virtually diagnostic of AML but not
pathognomonic as renal cell carcinomas rarely may
have fat components. Most lesions involve the cortex
and demonstrate macroscopic fat (20 Hounsﬁelds
Units on CT). When AML has typical appearance
there is essentially no diﬀerential diagnosis, but if atyp-
ical, especially when fat-poor, retroperitoneal liposar-
coma, adrenal myelolipoma, renal cell carcinoma,
oncocytoma, and Wilms’ tumor should be excluded.
In up to 4.5% of AML cases the tumor may be com-
posed mostly of smooth muscle cells and blood vessels
with minimal adipose tissue, and in these cases intra
tumor macroscopic fat may not be visible on CT,
mimicking and diﬃcult to distinguish from renal cell
carcinoma (4,5). Distinguishing AML from renal cell
carcinoma is critical in clinical management (20).
The major limitation of the present report is that it is
a small cohort of patients, because AML is a rare dis-
ease. Further, the study is retrospective, and treatment
was not given according to a prospective protocol, and
therefore sample bias may be present. Even though, it
has been possible to show that the embolization signiﬁ-
cantly has reduced the volume of the tumors, and no
recurrence of tumor growth or re-bleeding has been
demonstrated at long-term follow-up. Selective embol-
ization is nephron-sparing and non-embolized areas of
the kidney will be preserved and thus it is possible to
preserve normal total kidney function, like demon-
strated also in previous studies (13,14,21).
In conclusion, embolization of AMLs is an attractive
option, as it is a minimally invasive and nephron spar-
ing procedure. Selective arterial embolization is eﬀect-
ive for AML devascularization and volume reduction
which is long-lasting, and it has a long-term eﬃcacy in
preventing hemorrhagic complications of AML. It is
fast to perform and with few complications but 3/8 of
the patients have lost one kidney during the procedure
or the follow-up period.
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